Literature DB >> 14991353

The prevalence of oligoclonal bands in the CSF of patients with primary neurodegenerative dementia.

J C Janssen1, A K Godbolt, P Ioannidis, E J Thompson, M N Rossor.   

Abstract

BACKGROUND: Recent guidelines from the United States and Europe on the diagnosis and management of dementia include advice that younger patients with dementia should undergo CSF examination, which frequently includes analysis for oligoclonal bands (OCB). The presence of CNS specific OCB has traditionally been considered suggestive of an inflammatory aetiology, although the interpretation of such a finding in the presence of a normal CSF white cell count and protein is more difficult.
METHODS: We reviewed retrospectively the prevalence of OCB, determined using agarose isoelectric focusing, in a series of 131 well characterised patients with a final diagnosis of a degenerative dementia who had undergone CSF examination.
RESULTS: The mean age of the patients was 60.0 (SD 8.4) years. Seventy (53%) patients had Alzheimer's disease (AD), forty seven (36 %) had frontotemporal lobar degeneration (FTLD), seven (5%) had Dementia with Lewy bodies and the remaining seven (5%) patients had other rarer neurodegenerative dementias. Neuropathological examination had been performed in fifteen (11%) patients. CNS specific OCB were present in nine (7%) patients in this cohort, all of whom had normal CSF white cell counts: four AD patients (a prevalence of 6%), four FTLD patients (a prevalence of 9%), and one patient with Creutzfeldt-Jakob disease (a prevalence of 25%). Investigation of these patients, including two with neuropathologically verified AD and one with post-mortem confirmed CJD, did not reveal an alternative aetiology for their dementia.
CONCLUSION: A central immune response can occur in primary neurodegenerative dementias, albeit uncommonly.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14991353     DOI: 10.1007/s00415-004-0296-4

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  8 in total

1.  Summary of cerebrospinal fluid routine parameters in neurodegenerative diseases.

Authors:  Sarah Jesse; Johannes Brettschneider; Sigurd D Süssmuth; Bernhard G Landwehrmeyer; Christine A F von Arnim; Albert C Ludolph; Hayrettin Tumani; Markus Otto
Journal:  J Neurol       Date:  2010-12-25       Impact factor: 4.849

2.  Hypercapnia is a possible determinant of the function of the blood-cerebrospinal fluid barrier in amyotrophic lateral sclerosis.

Authors:  Sigurd D Süssmuth; Anne D Sperfeld; Albert C Ludolph; Hayrettin Tumani
Journal:  Neurochem Res       Date:  2010-03-24       Impact factor: 3.996

3.  Progressive myoclonic ataxia with intrathecal immune activation in six patients.

Authors:  D Testa; E Ambrosoni; S Franceschetti; A Salmaggi; P Soliveri; F Girotti
Journal:  Neurol Sci       Date:  2007-08-10       Impact factor: 3.307

4.  A multicenter study on the diagnostic significance of a single cerebrospinal fluid IgG band.

Authors:  Diana Ferraro; Diego Franciotta; Roberta Bedin; Claudio Solaro; Eleonora Cocco; Mario Santangelo; Paolo Immovilli; Alberto Gajofatto; Massimiliano Calabrese; Massimiliano Di Filippo; Riccardo Orlandi; Anna Maria Simone; Francesca Vitetta; Elisabetta Capello; Debora Giunti; Alessandra Murialdo; Jessica Frau; Sara Mariotto; Antongiulio Gallina; Claudio Gasperini; Patrizia Sola
Journal:  J Neurol       Date:  2017-04-05       Impact factor: 4.849

Review 5.  CSF markers in amyotrophic lateral sclerosis.

Authors:  Joanna Tarasiuk; Alina Kułakowska; Wiesław Drozdowski; Johannes Kornhuber; Piotr Lewczuk
Journal:  J Neural Transm (Vienna)       Date:  2012-05-04       Impact factor: 3.575

6.  Autoimmune dementia: clinical course and predictors of immunotherapy response.

Authors:  Eoin P Flanagan; Andrew McKeon; Vanda A Lennon; Bradley F Boeve; Max R Trenerry; K Meng Tan; Daniel A Drubach; Keith A Josephs; Jeffrey W Britton; Jayawant N Mandrekar; Val Lowe; Joseph E Parisi; Sean J Pittock
Journal:  Mayo Clin Proc       Date:  2010-10       Impact factor: 7.616

Review 7.  Rapidly progressive dementias - aetiologies, diagnosis and management.

Authors:  Peter Hermann; Inga Zerr
Journal:  Nat Rev Neurol       Date:  2022-05-04       Impact factor: 44.711

8.  Paraneoplastic and other autoimmune disorders of the central nervous system.

Authors:  Andrew McKeon
Journal:  Neurohospitalist       Date:  2013-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.